Evidence map›Paper›PMID 38721148›Full record

ArticleFrontiers in endocrinology2024

Genetic changes in the

Anastasiya V Snezhkina, Vladislav S Pavlov, Dmitry V Kalinin, Elena A Pudova, George S Krasnov, Asiya F Ayupova, Anastasiya A Kobelyatskaya, Alexey A Dmitriev, Dmitrii A Atiakshin, Maria S Fedorova and 1 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Non-Susceptibility Gene Variants in Head and Neck Paragangliomas.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anastasiya V SnezhkinaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Vladislav S PavlovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Dmitry V KalininVishnevsky Institute of Surgery, Ministry of Health of the Russian Federation, Moscow, Russia.
Elena A PudovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
George S KrasnovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Asiya F AyupovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Anastasiya A KobelyatskayaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Alexey A DmitrievEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Dmitrii A AtiakshinScientific and Educational Resource Center "Innovative Technologies of Immunophenotyping, Digital Spatial Profiling and Ultrastructural Analysis", RUDN University, Moscow, Russia.
Maria S FedorovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Anna V KudryavtsevaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vagal paraganglioma (VPGL) is a rare neuroendocrine tumor that originates from the paraganglion associated with the vagus nerve. VPGLs present challenges in terms of diagnostics and treatment. VPGL can occur as a hereditary tumor and, like other head and neck paragangliomas, is most frequently associated with mutations in the

Indexed as

Cranial Nerve NeoplasmsParagangliomaAcid Anhydride HydrolasesAdultExome SequencingFemaleGerm-Line MutationHumansVagus Nerve DiseasesAcid Anhydride Hydrolasesbiallelic inactivationFHhead and neck paragangliomaLOHmutation profilevagal paraganglioma

Identifiers

PMID38721148
PMCPMC11076847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.